Clindamycin
4 customer reviewsClindamycin is a lincosamide antibiotic used for susceptible bacterial infections in adults and some adolescents. It is for skin, dental, bone, soft tissue, and certain respiratory infections, especially when penicillin cannot be used. It stops bacteria from making essential proteins so the infection can slow down and clear.
What is it?
Clindamycin is a lincosamide antibiotic used to treat susceptible bacterial infections in adults and, in some cases, adolescents. It is used when the infection is caused by bacteria that respond to clindamycin, including many Gram‑positive organisms and some anaerobes. It works by stopping bacteria from making essential proteins, which slows growth and helps the immune system clear the infection.
Clindamycin is an antibiotic from the lincosamide class, used for a range of infections involving the skin and soft tissues, bones and joints, and parts of the respiratory tract. It is also used for certain dental infections and for anaerobic infections where oxygen-poor environments let bacteria thrive. For many prescribers, it is a practical option when a patient cannot use penicillins due to allergy, or when anaerobes are suspected based on the infection site. In practice, it fills a useful niche in mixed infections.
Composition
This product is Clindamycin in pill form for oral use.
- Clindamycin hydrochloride: used for oral pills.
- Clindamycin phosphate: commonly used for topical preparations and some parenteral products.
How to use?
Clindamycin pills are taken by mouth in divided doses as prescribed.
Practical dosing rules that reduce avoidable problems:
- Swallow with a full glass of water.
- Stay upright for at least 30 minutes after the dose to reduce oesophageal irritation (a real cause of “it hurts to swallow” calls to pharmacies).
- Food is optional; if nausea happens, taking it with food can help.
- Space doses evenly through the day to keep drug levels steady.
Missed dose guidance:
- Take it when you remember if it is not close to the next dose.
- If the next dose is soon, skip the missed dose and return to schedule.
- Do not double doses.
Course length matters. Stopping early often makes symptoms return and selects for resistant bacteria.
How does it work?
- Oral tablets: take 150–300 mg by mouth 4 times/day with a full glass of water, preferably after meals; for severe infections, the dose may be increased as prescribed, and treatment usually lasts 7–14 days.
- Topical forms: apply a thin layer to the affected area 1–2 times/day; use in the morning and evening if directed, and continue for the full course, usually 6–12 weeks.
- Vaginal use: insert the prescribed dose once daily at bedtime for the full treatment period as directed by a clinician.
- Injection form: administer as prescribed by a healthcare professional, with frequency and duration based on the type and severity of infection.
Indications
Clindamycin is used to treat bacterial infections caused by susceptible organisms, including:
- Skin and soft tissue infections (cellulitis, infected wounds, abscess-related infections after drainage)
- Bone and joint infections (selected cases, often guided by cultures)
- Respiratory tract infections where anaerobes may play a role (for example, aspiration-related infections)
- Dental and oral infections where anaerobic bacteria are common
For acne, clindamycin is widely used as a topical antibiotic in “Acne Care” regimens to reduce acne‑associated skin bacteria and calm inflammatory lesions; oral Clindamycin is not a routine first-line acne option because long courses increase resistance pressure. The MOHAP approach to antimicrobial stewardship in the UAE aligns with keeping systemic antibiotics for clear indications and appropriate durations. [3]
A key limitation: Clindamycin does not treat viral infections such as colds or influenza.
Comparison
Choice of antibiotic depends on the infection site, likely organisms, allergies, and local resistance patterns. A simple way to compare common options used for similar indications is by coverage and key trade-offs.
| Option (active ingredient) | Main clinical niche | Common limitations |
|---|---|---|
| Clindamycin | Skin/soft tissue infections, dental infections, anaerobic coverage, penicillin-allergy pathways | Higher risk of antibiotic-associated diarrhoea and C. difficile colitis |
| Amoxicillin/clavulanate | Mixed respiratory/dental flora, many bite-related infections | Not suitable in true penicillin allergy; can still cause diarrhoea |
| Doxycycline | Acne and some skin infections, community MRSA coverage in selected settings | Photosensitivity, oesophagitis risk, pregnancy restrictions |
A practical takeaway: Clindamycin is often chosen when anaerobes matter or when penicillin allergy narrows options, but the GI risk profile needs respect. It is not a casual first choice when safer alternatives fit.
Contraindications
- Allergy or hypersensitivity to clindamycin or lincomycin
- A history of antibiotic-associated colitis, including suspected or confirmed C. difficile colitis
- Severe hepatic dysfunction or severe renal dysfunction where dose adjustment and close monitoring are needed
- Pregnancy or breastfeeding without a clear medical indication and clinician supervision
Not recommended for
Clindamycin is not a good choice if you have had serious antibiotic-related bowel problems before. Be especially careful if you have ongoing diarrhoea, inflammatory bowel disease, or a past reaction to clindamycin or lincomycin. Extra caution is also needed in pregnancy or breastfeeding unless a clinician says the benefit is clear.
Side effects
Gastrointestinal effects are the most common with oral clindamycin.
- Diarrhoea
- Nausea
- Abdominal pain
- Vomiting
Skin reactions can occur:
- Rash
- Itching (pruritus)
- Hives (urticaria)
A rare but serious risk is antibiotic‑associated colitis due to C. difficile, which can present with frequent watery diarrhoea, fever, cramping, and dehydration. This risk is a core safety message across regulatory references for systemic clindamycin. [4]
Common mistakes
A few patterns show up repeatedly in day-to-day pharmacy follow-up.
- People stop after 2–3 days because swelling or pain improved, then the infection returns a week later and is harder to treat.
- Doses get taken “whenever I remember,” which creates long gaps; protein-synthesis inhibitors work best with consistent spacing.
- Patients take the pill right before lying down, then develop severe throat or chest pain from oesophageal irritation.
- Diarrhoea gets self-treated with anti-motility agents even when fever or cramping is present; this can delay care in C. difficile colitis.
- Topical acne routines get mixed up: retinoids like tretinoin are layered with multiple irritants on day one, then the patient quits everything from burning and peeling.
Doctor opinions
There is also a consistent caution: gastrointestinal intolerance drives non-adherence. Many prescribers proactively discuss diarrhoea early, because patients often stop the medicine without telling anyone once symptoms improve. A second caution is antimicrobial resistance; clinicians increasingly align with WHO and local stewardship principles by using the shortest effective course and narrowing therapy once microbiology results return. [5]
Frequently asked questions
Symptom relief often begins within 24–72 hours, depending on the infection site and whether drainage or other procedures were needed. Fever and pain may improve first, while redness or swelling can take longer to settle. Lack of any improvement by about day three is a common reason clinicians reassess and consider cultures or an alternative antibiotic. WHO guidance on antibiotic use supports reassessment rather than simply extending a course without a plan.
Clindamycin is used in acne care most often as a topical antibiotic, aimed at reducing acne-associated bacteria on the skin and calming inflammatory lesions. Oral clindamycin is not a routine first-choice acne treatment because longer systemic courses increase resistance pressure and raise GI risks. Dermatology practice often pairs topical antibiotics with benzoyl peroxide to reduce resistance selection, while retinoids such as adapalene or tretinoin are used to prevent comedones. EMA safety materials for systemic clindamycin keep the focus on using oral therapy only for clear, appropriate indications.
Watery diarrhoea that is frequent, persistent, or paired with fever, severe cramps, blood, or dehydration deserves urgent medical assessment. The main concern is antibiotic-associated colitis, including C. difficile, which needs targeted management rather than routine anti-diarrhoea medicines. This risk is well described in systemic clindamycin safety references and is one reason clinicians avoid unnecessary antibiotic use. EMA patient safety information highlights the need to act early when these symptoms appear.
Clindamycin is often used as an alternative in patients with penicillin allergy, especially for dental and skin infections where anaerobes or Gram-positive bacteria are suspected. Allergy history still matters: a previous reaction to clindamycin or lincomycin is a contraindication. Clinicians also look at the infection type and local resistance patterns before choosing it. MOHAP antimicrobial stewardship messaging in the UAE supports allergy-informed prescribing that avoids unnecessary broad-spectrum exposure.
For acne regimens, topical clindamycin can be used alongside tretinoin or adapalene, but irritation and dryness are more likely because retinoids increase skin turnover. Spacing products through the day and starting retinoids slowly (every other night first) often improves tolerance. If severe redness, peeling, or burning occurs, clinicians commonly adjust frequency rather than abandoning treatment entirely. These combination patterns appear in dermatology guidelines and reflect routine clinical practice rather than a single fixed “one way” protocol.
Clindamycin may be used in pregnancy or breastfeeding when the indication is strong and alternatives are not suitable, but it is typically a clinician-led decision. The infection site, severity, and culture results influence the choice, and monitoring for GI intolerance is still important. For breastfeeding, clinicians weigh infant GI effects and maternal benefit, and may suggest observing for diarrhoea or thrush in the infant. Regulatory references such as the EMA product information describe these cautions for systemic therapy.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Clindamycin — Comparison with alternatives
Clindamycin Current Best rated
Tobradex
Chlorhexidine
Amoxil Best price
Zithromax
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2023). Summary of Product Characteristics (SmPC) — clindamycin (systemic use). ↑
- World Health Organization (WHO) (2023). AWaRe Classification Database of antibiotics. ↑
- MOHAP (Ministry of Health and Prevention, UAE) (2022). National Action Plan on Antimicrobial Resistance (AMR). ↑
- U.S. Food and Drug Administration (FDA) (2022). Clindamycin — Prescribing Information (systemic formulations). ↑